Tech Company Financing Transactions
Vasogenix Pharmaceuticals Funding Round
Vasogenix Pharmaceuticals, operating out of Lenexa, secured $600 thousand from Kansas Technology Enterprise Corporation.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$600,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8527 Bluejacket Street
Lenexa, KS 66214
USA
Lenexa, KS 66214
USA
Phone
Website
Email Address
Not Recorded
Overview
VasoGenix Pharmaceuticals, Inc., is developing intravenous (IV) and controlled release drug treatments for addressing Heart Failure (HF) and other cardiac diseases in order to reduce the recurrence of these diseases and their resulting hospital and medical costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lee Southard
Browse more venture capital transactions:
Prev: 9/30/2009: Celula venture capital transaction
Next: 9/30/2009: Solyndra venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs